Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Infectious Disease Prevention

Background:

• Perinatal group B streptococcal (GBS) disease prevention guidelines were first issued by the CDC in 1996 and AAP in 1997.
• Revised CDC guidelines in 2002 recommended universal antenatal GBS screening, leading to an 80% decrease in early-onset GBS disease.
• Despite reductions, GBS disease remained the leading cause of early-onset neonatal sepsis in 2010.

Purpose of the Study:

• To review and discuss the key differences between the 2002 and 2010 CDC guidelines for perinatal GBS disease prevention.
• To highlight changes most relevant to pediatric practice.
• To provide an updated understanding of GBS prevention strategies.

Main Methods:

• Review of the 2002 and 2010 CDC guidelines for GBS disease prevention.
• Analysis of changes in recommendations regarding screening, prophylaxis, laboratory methods, and newborn care.
• Comparison of strategies for women with preterm labor, premature rupture of membranes, and penicillin allergy.

Main Results:

• The 2010 guidelines reaffirm universal antenatal GBS screening and intrapartum antibiotic prophylaxis.
• New recommendations include updated laboratory methods for GBS identification.
• Revised algorithms address screening and prophylaxis for specific obstetric conditions and penicillin-allergic women.

Conclusions:

• The 2010 CDC guidelines provide comprehensive updates for perinatal GBS disease prevention.
• These guidelines aim to further reduce the incidence of neonatal sepsis caused by GBS.
• Adherence to updated guidelines is crucial for effective GBS disease prevention in newborns.